Precipio, Inc. (PRPO)
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
$9.29M
Mr. Ilan Danieli
55.00
New Haven, CT
Jul 18, 2000
-2.74
$-2.29
0.55
0.92
-98.23%
-16.10
0.08
12.35
0.89
0.73
-55.27%
-68.67%
Similar stocks (11)
Natera, Inc.
NTRA
Twist Bioscience Corporation
TWST
CareDx, Inc
CDNA
Castle Biosciences, Inc.
CSTL
Biodesix, Inc.
BDSX
Sera Prognostics, Inc.
SERA
Exagen Inc.
XGN
bioAffinity Technologies, Inc.
BIAF
Star Equity Holdings, Inc.
STRR
Psychemedics Corporation
PMD
Applied DNA Sciences, Inc.
APDN
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (11)
Natera, Inc.
NTRA
Twist Bioscience Corporation
TWST
CareDx, Inc
CDNA
Castle Biosciences, Inc.
CSTL
Biodesix, Inc.
BDSX
Sera Prognostics, Inc.
SERA
Exagen Inc.
XGN
bioAffinity Technologies, Inc.
BIAF
Star Equity Holdings, Inc.
STRR
Psychemedics Corporation
PMD
Applied DNA Sciences, Inc.
APDN
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%